Investing in bio-tech is an interesting field imo, however, separating the wheat from the chaff can be difficult, especially for junior biotech investors such as myself.
Appreciate the continuing education of your board.
Agree - but that myopic behavior isn’t really particularly helpful even in small research labs. It just gets less visibility. Interestingly biotech CEOs who’ve come from WS, or other areas where they see a LOT of biotechs from 50k ft, seem to have a higher hit rate?